Add BrightSurf on Google Email

Study illuminates benefits of red blood cell exchange in severe babesiosis

A multicenter study found that red blood cell exchange transfusion significantly improves clinical outcomes for patients hospitalized with severe babesiosis, a potentially life-threatening tick-borne infection. The procedure was associated with substantially lower risk of in-hospital death or readmission.

SourceBrigham and Women's Hospital·JournalJAMA Internal Medicine·TypeRandomized controlled/clinical trial·DateMar 30, 2026

The Lancet Neurology: Over 250,000 deaths from meningitis globally in 2023; over one third in children under five, suggests most comprehensive global assessment to date

Globally, meningitis resulted in over 259,000 deaths and 2.5 million infections in 2023, according to a comprehensive study. The disease disproportionately affects low-income countries, particularly in Africa, where air pollution, premature birth, and low birthweight are major risk factors for death.

SourceThe Lancet·JournalThe Lancet Neurology·TypeObservational study·DateMar 27, 2026

Severe infections may raise dementia risk, study finds

A Finnish registry study found that severe infections, such as cystitis and bacterial disease, are associated with an increased risk of dementia. The study examined nationwide health registry data and identified 29 diseases linked to dementia risk, including mental disorders, Parkinson's disease, and alcohol-related mental disorders.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateMar 24, 2026

Use of controversial weedkiller inadvertently selects for drug-resistant bacteria that can spread to hospitals

Scientists have found evidence that glyphosate, a widely used weedkiller, can select for drug-resistant bacteria that can thrive in agricultural areas and then spread to hospitals. The study revealed that bacterial strains from hospital infections with extreme drug resistance showed high resistance to glyphosate and its byproducts.

SourceFrontiers·JournalFrontiers in Microbiology·TypeExperimental study·DateMar 24, 2026

New estimates of uncounted COVID-19 deaths reveal critical gaps in US death investigation system

A new study found that over 155,000 US deaths between March 2020 and December 2021 were not officially recorded as COVID-19 deaths, highlighting critical gaps in the death investigation system. These unrecognized deaths disproportionately affected certain populations, including racial and ethnic minorities.

SourceBoston University School of Public Health·JournalScience Advances·TypeComputational simulation/modeling·DateMar 19, 2026

ACP supports AAP’s evidence‑based childhood vaccine schedule

The American College of Physicians (ACP) supports the American Academy of Pediatrics' (AAP) 2026 childhood vaccine schedule, which is based on evidence and better reflects current disease epidemiology. The ACP's Immunization Committee found the AAP recommendations to be more evidence-based than the CDC's recommendations, particularly i...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateMar 16, 2026

Targeting two flu proteins sharply reduces airborne spread

A study in ferrets demonstrates that immunity to two proteins on the surface of the influenza virus can reduce transmission and viral evolution. Targeting both hemagglutinin and neuraminidase proteins can effectively curb the spread of the virus, with transmission rates dropping by half in animals with immunity to both.

SourcePenn State·JournalScience Advances·TypeExperimental study·DateMar 13, 2026

Q&A: What factors influence likelihood and severity of Ebola outbreaks?

Researchers at Penn State found that Ebola outbreaks are influenced by environmental and human factors, including weather patterns, vegetation health, and human movement. A strong positive correlation was found between the total length of roads and rivers in outbreak locations and the number of Ebola cases reported early in each outbreak.

SourcePenn State·JournalBiology Letters·TypeObservational study·DateMar 12, 2026

Foreign aid cuts to tuberculosis services could cost families $80 billion worldwide

A new study warns that reduced international funding for tuberculosis services could lead to significant economic hardship for 40 million households globally, with the poorest households bearing the greatest burden. The study estimates that complete elimination of external funding for TB could cost families up to $80 billion annually.

SourceBoston University School of Public Health·JournalPLOS Medicine·TypeComputational simulation/modeling·DateMar 11, 2026

Building protection against infectious diseases with nanostructured vaccines

Researchers at the Wyss Institute developed DoriVac, a DNA nanotechnology-enabled vaccine platform that induces broad immunity against infectious viruses, including SARS-CoV-2, HIV, and Ebola. The platform produces potent antigen-specific immune responses and is more stable and easier to manufacture than traditional vaccine platforms.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateMar 11, 2026

Low-cost preventive measures could mitigate spread of bacteria causing neonatal mortality

A new study discovered that a multifaceted infection prevention and control intervention successfully disrupted a large and long-running bacterial outbreak of Klebsiella pneumoniae in a Zambian neonatal intensive care unit. The study found that low-cost measures, including IPC training, enhanced cleaning, and hand hygiene, reduced neon...

SourceBoston University School of Public Health·JournalPLOS Global Public Health·TypeObservational study·DateMar 10, 2026

Mpox immune test validated during Rwandan outbreak

Researchers developed an antibody test for Mpox that accurately identifies those with infection and vaccine-derived antibodies, helping authorities prioritize vaccine use and study disease transmission. The test, validated in Rwanda, uses only four key antibody signatures to ensure affordability and accessibility.

SourceUniversity of Birmingham·JournalThe Lancet Infectious Diseases·TypeExperimental study·DateMar 9, 2026

Using the vagus nerve to treat disease: Review maps today’s science, points to tomorrow’s therapies

A comprehensive review synthesizes the science behind vagus nerve modulation therapies, which use controlled signals to influence brain circuits and inflammation. The authors identify key mechanisms and propose next-generation treatments tailored to individual patients and conditions.

SourceUniversity of California - San Diego·JournalComprehensive Physiology·TypeSystematic review·DateMar 5, 2026

How viruses mess with our brains

A review of 900 scientific articles identified several biological markers associated with cognitive decline in viral infections, including activated monocytes and pro-inflammatory cytokines. Conversely, certain markers like anti-inflammatory cytokines are linked to better preservation of cognitive abilities.

SourceUniversité de Genève·JournalNeuroscience & Biobehavioral Reviews·TypeNews article·DateMar 5, 2026

Missed opportunity to protect pregnant women and newborns: Study shows low vaccination rates among expectant mothers in Norway against COVID-19 and influenza

A study of over 50,000 pregnant women in Norway found low vaccination rates against COVID-19 and influenza, with only 29.9% and 12.1% vaccinated respectively. The study highlights the need for targeted strategies to improve vaccination uptake among expectant mothers.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateFeb 19, 2026

Children’s Hospital of Philadelphia, Penn Medicine Researchers identify strategies for preventing the most infectious strains of S. aureus in the NICU

A new study identifies the most infectious strains of Staphylococcus aureus in neonatal intensive care units and suggests specific strategies for prevention and control. The research provides a critical blueprint for precision surveillance and aims to reduce infections in vulnerable newborns.

SourceChildren's Hospital of Philadelphia·JournalNature Communications·TypeObservational study·DateFeb 10, 2026

Study reveals how chills develop and support the body's defense against infection

A recent rat study identified the neural mechanism underlying chills, a cold sensation that supports the body's response to infection. The findings suggest that prostaglandin E₂ boosts cold signals from the lateral parabrachial nucleus to the central nucleus of the amygdala, triggering chills and promoting warmth-seeking behavior.

SourceNagoya University·JournalThe Journal of Physiology·TypeExperimental study·DateFeb 10, 2026

Pediatric Investigation study reports significant shifts in post-COVID respiratory infection trends in children

A recent study found significant changes in post-COVID respiratory infections among children, with Mycoplasma pneumoniae experiencing a surge after restrictions were lifted. The study also revealed strong interactions between pathogens, including negative correlations and pathogen interference.

SourcePediatric Investigation·JournalPediatric Investigation·TypeObservational study·DateFeb 2, 2026

Wastewater surveillance reveals true scale of COVID-19 spread as clinical testing declines

A study in Japan found that wastewater surveillance can uncover the true scale of COVID-19 spread by detecting high viral loads in sewage despite reduced clinical testing. This approach offers an objective view of community-wide infection levels, unaffected by changes in testing policies or public behavior.

SourceThe University of Osaka·JournalEnvironment International·TypeObservational study·DateJan 28, 2026

Nearly half of CDC surveillance databases have halted updates, raising concerns about health data gaps

Nearly half of CDC surveillance databases have stopped updating, primarily tracking vaccination-related information and respiratory diseases. Prolonged pauses risk weakening evidence-based decision-making, and the authors recommend clear status updates, reasons for delays, and timelines for resuming data publication.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeNews article·DateJan 26, 2026